wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37697125-0B87DBE0-8E32-481D-9877-CF3DBA328028
Q37697125-0B87DBE0-8E32-481D-9877-CF3DBA328028
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697125-0B87DBE0-8E32-481D-9877-CF3DBA328028
Is there a benefit of first- or second-line crizotinib in locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer? a meta-analysis.
P2860
Q37697125-0B87DBE0-8E32-481D-9877-CF3DBA328028
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697125-0B87DBE0-8E32-481D-9877-CF3DBA328028
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
920017edee80975ea22999e0e7083f29e7fde5f4
P2860
Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib.